Is Methylphenidate Hydrochloride Tablet, Extended Release (Concerta) in shortage?
Yes. Methylphenidate Hydrochloride Tablet, Extended Release is on FDA’s drug shortage list (unavailable), last updated Oct 1, 2026.
Why it’s in shortage
- Demand increase for the drug
- Discontinuation of the manufacture of the drug
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)
Allocation to current contracted customers
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)
Estimated recovery: October 2026
Maker contact: 800-545-8800
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)
Estimated recovery: October 2026
Maker contact: 800-545-8800
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)
Maker contact: 800-545-8800
- Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)
Maker contact: 800-545-8800
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)
Maker contact: 844-834-0530
- Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)
Estimated recovery: November 2026
Maker contact: 844-834-0530
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)
Estimated recovery: November 2026
Maker contact: 844-834-0530
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)
Maker contact: 844-834-0530
- Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)
Maker contact: 800-541-4802
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)
Maker contact: 800-541-4802
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)
Currently not marketed
Maker contact: 800-818-4555
- Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)
Currently not marketed
Maker contact: 800-818-4555
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)
Currently not marketed
Maker contact: 800-818-4555
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)
Currently not marketed
Maker contact: 800-818-4555
- Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET
- Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)
Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET
- Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)
Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET
- Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)
Maker contact: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET
FDA recalls of Methylphenidate Hydrochloride
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Methylphenidate Hydrochloride Tablet, Extended Release:
- Trigen Laboratories recalls Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories
- RISING PHARMACEUTICALS recalls Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising
- Teva Pharmaceuticals USA recalls Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
- Teva Pharmaceuticals USA recalls Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
- Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC
- Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories,
- Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories,
- Novartis Pharmaceuticals Corp. recalls Ritalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp.
- Novartis Pharmaceuticals Corp. recalls Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp.
- Teva Pharmaceuticals USA, Inc. recalls Methylphenidate Hydrochloride Extended-Release Capsules (LA), 30 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS
- Teva Pharmaceuticals USA, Inc. recalls Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS
Methylphenidate Hydrochloride Tablet, Extended Release shortage questions
Is Methylphenidate Hydrochloride Tablet, Extended Release (Concerta) in shortage?
Yes. Methylphenidate Hydrochloride Tablet, Extended Release is on FDA’s drug shortage list (unavailable), last updated Oct 1, 2026.
Why is there a Methylphenidate Hydrochloride Tablet, Extended Release shortage?
FDA records the reason as: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other.
What should I do if I can’t get Methylphenidate Hydrochloride Tablet, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.